Julie C. Smith

873 total citations
17 papers, 179 citations indexed

About

Julie C. Smith is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Julie C. Smith has authored 17 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Julie C. Smith's work include Breast Cancer Treatment Studies (3 papers), Infant Development and Preterm Care (2 papers) and Cancer Treatment and Pharmacology (2 papers). Julie C. Smith is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Infant Development and Preterm Care (2 papers) and Cancer Treatment and Pharmacology (2 papers). Julie C. Smith collaborates with scholars based in United States, Australia and Japan. Julie C. Smith's co-authors include Thomas E. Merchant, Chenghong Li, Tina Davis, Xiaoping Xiong, Mitchell Garrison, John M. Pagel, Ajay K. Gopal, George F. Gjerset, Andrei R. Shustov and Stephen H. Petersdorf and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Julie C. Smith

17 papers receiving 167 citations

Peers

Julie C. Smith

ONCOL

RNMI

PFM

PRM

EPIDE

M. C. Pant India

M Corbo United States

Eric Wadman United States

Qiufei Ma United States

Reika Takamatsu Japan

Judith R. Casley‐Smith Australia

Xinaida Taligare Vasconcelos Lima United States

Yanjiao Lu China

Sheeba Murad Pakistan

Zizi Yu United States

M. C. Pant India

Julie C. Smith

27 ×0.5

ONCOL

52 ×1.5

RNMI

27 ×0.8

PFM

87 ×2.9

PRM

28 ×0.9

EPIDE

Citations per year, relative to Julie C. Smith Julie C. Smith (= 1×) peers M. C. Pant

Countries citing papers authored by Julie C. Smith

Since Specialization

Citations

This map shows the geographic impact of Julie C. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie C. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie C. Smith more than expected).

Fields of papers citing papers by Julie C. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie C. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie C. Smith. The network helps show where Julie C. Smith may publish in the future.

Co-authorship network of co-authors of Julie C. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Julie C. Smith. A scholar is included among the top collaborators of Julie C. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie C. Smith. Julie C. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Sawyer, Brook E., et al.. (2024). Parents Plus: A Parent-Implemented Intervention for Preschool Children With Developmental Language Disorders. Language Speech and Hearing Services in Schools. 56(1). 177–193. 1 indexed citations

Sawyer, Brook E., et al.. (2022). Developing Parents Plus. Infants & Young Children. 35(3). 205–221. 4 indexed citations

Kreizenbeck, Karma L., Tracy Wong, Barbara Jagels, et al.. (2020). Results of a pilot study to increase adherence to ASCO G-CSF recommendations at community clinics.. Journal of Clinical Oncology. 38(29_suppl). 19–19. 1 indexed citations

Kreizenbeck, Karma L., Tracy Wong, Barbara Jagels, et al.. (2020). Baseline cancer worry and tumor marker testing among earlier-stage breast cancer patients participating in a Choosing Wisely pilot.. Journal of Clinical Oncology. 38(29_suppl). 153–153. 1 indexed citations

Kreizenbeck, Karma L., Tracy Wong, Barbara Jagels, et al.. (2020). A pilot study to increase adherence to ASCO Choosing Wisely recommendations for breast cancer surveillance at community clinics.. Journal of Clinical Oncology. 38(29_suppl). 18–18. 2 indexed citations

Linden, Hannah M., Vijayakrishna K. Gadi, Larissa A. Korde, et al.. (2018). Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib. Clinical Breast Cancer. 19(2). e283–e296. 29 indexed citations

Kreizenbeck, Karma L., Lotte Steuten, Veena Shankaran, et al.. (2016). Value in cancer care: Regional initiative to improve care through data reporting and interventions.. Journal of Clinical Oncology. 34(7_suppl). 34–34. 1 indexed citations

Robinson, Philip, Michael S. Schechter, Peter D. Sly, et al.. (2012). Clarithromycin therapy for patients with Cystic Fibrosis: A randomized controlled trial. Pediatric Pulmonology. 47(6). 551–557. 17 indexed citations

Smith, Julie C.. (2012). Successful Treatment of HER2-neu-Positive Breast Cancer with Paclitaxel and Trastuzumab Supplemented with Turkey Tail Mushrooms and Community Support. Global Advances in Health and Medicine. 1(5). 16–17. 1 indexed citations

10.

Smith, Julie C., et al.. (2011). Producing Instructional Videos Through Collaborative-Action Research for People Living With an Intellectual Disability. EdMedia: World Conference on Educational Media and Technology. 2011(1). 1504–1509. 2 indexed citations

11.

Gopal, Ajay K., Oliver W. Press, Andrei R. Shustov, et al.. (2010). Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium. Leukemia & lymphoma. 51(8). 1523–1529. 35 indexed citations

12.

Press, Oliver W., Andrei R. Shustov, Stephen H. Petersdorf, et al.. (2008). A Prospective Multicenter Phase II Study by the Puget Sound Oncology Consortium (PSOC) of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma. Blood. 112(11). 2585–2585. 1 indexed citations

13.

Merchant, Thomas E., et al.. (2007). A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiation Oncology. 2(1). 45–45. 44 indexed citations

14.

Smith, Julie C., et al.. (2003). A phase III trial comparing an anionic phospholipid-based (APP) cream and aloe vera-based gel in the prevention and treatment of radiation dermatitis. International Journal of Radiation Oncology*Biology*Physics. 57(2). S438–S438. 15 indexed citations

15.

Kfoury, Abdallah G., Julie C. Smith, Daniel Terreros, et al.. (1997). Adjuvant intrapleural amphotericin B therapy for pulmonary mucormycosis in a cardiac allograft recipient. Clinical Transplantation. 11(6). 608–612. 16 indexed citations

16.

Smith, Julie C.. (1995). Voice of the people : the European Parliament in the 1990s. OpenGrey (Institut de l'Information Scientifique et Technique). 3 indexed citations

17.

Smith, Julie C.. (1990). Public librarian perceptions of library users as self-directed learners. UMI Dissertation Services eBooks. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact